Gelonghui, February 24 — The three major U.S. stock indices all closed down more than 1%, with the Dow Jones down 1.66%, the Nasdaq down 1.13%, and the S&P 500 down 1.04%. Most large tech stocks declined, with Microsoft and Netflix falling over 3%, Tesla, Amazon, and Meta dropping more than 2%, and Google and Intel down over 1%; Apple and Nvidia saw slight gains. IBM fell over 13%, the largest decline since 2000. Novo Nordisk dropped over 16% after clinical trials showed its product CagriSema was less effective than Lilly’s Zepbound. Cancer cell therapy company Arcellx surged over 77%, reportedly being acquired by Gilead Sciences at $115 per share. Visa fell over 4%, the largest single-day decline since June last year; Mastercard dropped over 5%, the biggest since April last year.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The three major U.S. stock indices all closed down more than 1%. IBM experienced its largest decline since 2000.
Gelonghui, February 24 — The three major U.S. stock indices all closed down more than 1%, with the Dow Jones down 1.66%, the Nasdaq down 1.13%, and the S&P 500 down 1.04%. Most large tech stocks declined, with Microsoft and Netflix falling over 3%, Tesla, Amazon, and Meta dropping more than 2%, and Google and Intel down over 1%; Apple and Nvidia saw slight gains. IBM fell over 13%, the largest decline since 2000. Novo Nordisk dropped over 16% after clinical trials showed its product CagriSema was less effective than Lilly’s Zepbound. Cancer cell therapy company Arcellx surged over 77%, reportedly being acquired by Gilead Sciences at $115 per share. Visa fell over 4%, the largest single-day decline since June last year; Mastercard dropped over 5%, the biggest since April last year.